New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
11:03 EDTDDD, SSYS, VJET, XONE, GE, SYK, JNJ3D printer makers tumble after profit warning from 3D Systems
Shares of 3D printer makers are sinking after the largest company in the sector in terms of market capitalization, 3D Systems (DDD), pre-announced lower than expected fiscal 2013 profit and gave a disappointing earning outlook for next year. WHAT'S NEW: 3D Systems reduced its fiscal 2013 earnings per share outlook to 83c-87c from 93c-$1.03. Analysts' consensus estimate was 96c. However, the company reported preliminary fiscal 2013 revenue of $513 million-$514 million, within its previous outlook of $500M-$530M. Analysts' consensus estimate was $514.24M. 3D Systems blamed its lower than expected fiscal 2013 EPS on "very significant R&D, manufacturing and marketing investments designed to accelerate revenue growth," along with weaker than expected demand for its parts and consumer products. For fiscal 2014, 3D Systems predicted that its EPS would be 73c-85c, versus analysts' consensus estimate of $1.27. However, the 3D printer maker expects its fiscal 2014 revenue to come in at $680M-$720M, versus the consensus estimate of $671.29M. ANALYST REACTION: In a note to investors earlier today, Jefferies analyst Peter Misek wrote that 3D Systems' opportunity in the professional and industrial markets is "only just beginning." 3D Systems' guidance is "appropriately conservative," wrote Misek, adding that his research suggests that the 3D printer maker is likely to announce deals with at least three major companies in 2014: Stryker (SYK), Johnson & Johnson (JNJ), and GE (GE). Misek kept a Buy rating on the stock. PRICE ACTION: In mid-morning trading, 3D Systems tumbled 22% to $59.25, but the stock was well above its low for the day of $54.63. Likewise, another major 3D printer maker, Stratasys (SSYS), retreated 8% to $108.60, but was well off its low for the day of $102.20. Another company in the space, ExOne (XONE), sank 10% to $40.27, while European 3D printer maker Voxeljet (VJET) gave back 6% to trade near $32.
News For DDD;SSYS;VJET;XONE;GE;SYK;JNJ From The Last 14 Days
Check below for free stories on DDD;SSYS;VJET;XONE;GE;SYK;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 15, 2014
07:46 EDTJNJJohnson & Johnson reports Q2 EPS excluding items $1.66, consensus $1.55
Subscribe for More Information
06:50 EDTGEGE anticipates meeting $30B air show goal, Reuters says
Subscribe for More Information
July 14, 2014
15:24 EDTJNJNotable companies reporting before tomorrow's open
Subscribe for More Information
15:19 EDTJNJ Johnson & Johnson July 105 straddle priced for 1.6% move into Q2
14:27 EDTJNJEarnings Preview: J&J pharmaceutical sales expected to drive Q2
Johnson & Johnson (JNJ) is scheduled to report second quarter earnings before the market open on Tuesday, July 15, with a conference call scheduled for 8:30 am ET. Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. EXPECTATIONS: Analysts are looking for earnings per share of $1.55 on revenue of $18.94B, according to First Call. The consensus range for EPS is $1.45-$1.61 on revenue of $18.55B-$19.30B. LAST QUARTER: Johnson & Johnson reported first quarter EPS of $1.54 against estimates of $1.48 on revenue of $18.1B against estimates of $18B. The drug maker raised its fiscal year EPS view to $5.80-$5.90 against a consensus estimate of $5.83. J&J noted a 3.2% decrease in worldwide consumer sales in Q1 but saw a 10.8% increase in worldwide pharmaceutical sales. Primary contributors to operational sales growth in Q1 pharmaceutical sales were Stelara, Invega, Sustenna/Xeplion, Prezista, Velcade and sales of new products. Pharmaceutical sales results were negatively impacted by loss of exclusivity for Aciphex, a proton pump inhibitor for gastrointestinal disorders and Concerta for the treatment of attention deficit hyperactivity disorder. STREET RESEARCH: On July 14, RBC Capital raised its Q2 estimates for Johnson & Johnson to reflect the firm's outlook for higher pharmaceutical sales by the company. The firm raised its price target on the shares to $110 from $106 and kept an Outperform rating on the stock. PRICE ACTION: Shares of Johnson & Johnson are up approximately 8.5% since its last earnings report, and are trading near flat in afternoon trading.
12:24 EDTJNJJohnson & Johnson technical notes before earnings
The company is scheduled to report before market open on July 15th. The shares in the prior three months have risen by more than 8%, anticipating positive news for the current and forthcoming quarters. At the current price of $105.39, the only remaining established resistance on the daily chart is at the life high of $106.74. If the news and guidance is better than expected, a run to $110, or $115 at an extreme, would be possible. If the news fails to meet expectations or guidance is weak, support would be at $102.70, the 50-day moving average. A break below this uptrend support proxy would be a sell signal in many technical trading systems and would break an uptrend in place since early March of this year. On a sliding scale of increasingly weaker news, supports would next be at $99.96, and then at $96.87.
09:06 EDTGEEmirates signs $13B GE9X services agreement
Subscribe for More Information
08:30 EDTJNJJohnson & Johnson should be bought on any weakness, says RBC Capital
Subscribe for More Information
07:58 EDTSSYSMakerBot, Home Depot to bring MakerBot 3D printers to select stores
MakerBot, a subsidiary of Stratasys (SSYS), and The Home Depot (HD) announce a collaboration to bring MakerBot Replicator Desktop 3D Printers to customers on homedepot.com/makerbot and in 12 Home Depot stores in California, Illinois and New York beginning July 14. This is the first time The Home Depot has offered 3D printers for sale in its stores and will be a pilot program for MakerBot and The Home Depot.
07:43 EDTGEGE far ahead of Caterpillar in race for cleaner diesel train, WSJ says
Caterpillar (CAT) has fallen far behind in the race to offer a locomotive that meets stricter emission standards taking effect next year, with its Electro-Motive Diesel unit stating that its freight trains probably won't be available until 2017, while General Electric (GE) is already testing trains that comply with the new rules, reported The Wall Street Journal. Reference Link
July 13, 2014
11:40 EDTGEAmerican selects CFM engine to power A320 in order valued $2.6B
American Airlines (AAL) has selected CFM International’s advanced LEAP-1A engine to power its new fleet of 100 Airbus (EADSY) A320neo family aircraft. CFM values the engine order at $2.6B U.S. at list price. The aircraft order was originally announced in July 2011 and American will begin taking delivery in 2017. American also has orders for LEAP-1B engines to power 100 Boeing 737 MAX aircraft, which are also scheduled to be delivered beginning in 2017. American has been a CFM customer since 1996 and the airline’s fleet includes 375 Airbus A320 Family and Boeing 737 aircraft powered by CFM56 engines. CFM International is a 50/50 joint company between Safran and General Electric (GE).
July 12, 2014
18:08 EDTGEeasyJet said to choose GE-Safran engine for Airbus jets, WSJ says
easyJet (ESYJY) is set to order engines from a partnership of General Electric (GE) and France's Safran to power 100 Airbus Group (EADSY) NV A320neo jets, says the Wall Street Journal. According to the WSJ report United Technologies (UTX) unit Pratt & Whitney was also aggressively competing for the order. Reference Link
July 11, 2014
08:05 EDTGEGE Capital increases credit facility for OraMetrix
GE Capital’s Healthcare Financial Services business announced that it is the sole lender on a $10M senior secured term loan for OraMetrix. This transaction refinances the company’s previous $7.5M multi-draw senior secured term loan facility and provides it with an additional $2.5M. The funds will be used for working capital and growth initiatives.
08:03 EDTGEGE Capital provides MerchSource with $130M credit facility
GE Capital announced it is providing MerchSource with a $130M senior credit facility providing working capital for the company’s operations in the U.S. and Hong Kong.
07:45 EDTGEWith Alstom agreement settled, attention on GE turns to earnings, Reuters says
Subscribe for More Information
07:36 EDTJNJJohnson & Johnson Q2 EPS likely to exceed expectations, says Bernstein
Subscribe for More Information
July 10, 2014
14:26 EDTSSYST. Rowe Price reports 10.7% passive stake in Stratasys
10:09 EDTSSYSStratasys management to meet with Jefferies
Subscribe for More Information
07:29 EDTGEGeneral Electric volatility elevated into Q2 and revenue outlook
Subscribe for More Information
06:42 EDTSYKBiomet reports Q4 net sales up 7.7% to $844.5M
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use